These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17300633)

  • 1. A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.
    Janssens B; van Herp M; Goubert L; Chan S; Uong S; Nong S; Socheat D; Brockman A; Ashley EA; Van Damme W
    Trop Med Int Health; 2007 Feb; 12(2):251-9. PubMed ID: 17300633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
    Ashley EA; Krudsood S; Phaiphun L; Srivilairit S; McGready R; Leowattana W; Hutagalung R; Wilairatana P; Brockman A; Looareesuwan S; Nosten F; White NJ
    J Infect Dis; 2004 Nov; 190(10):1773-82. PubMed ID: 15499533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
    Valecha N; Phyo AP; Mayxay M; Newton PN; Krudsood S; Keomany S; Khanthavong M; Pongvongsa T; Ruangveerayuth R; Uthaisil C; Ubben D; Duparc S; Bacchieri A; Corsi M; Rao BH; Bhattacharya PC; Dubhashi N; Ghosh SK; Dev V; Kumar A; Pukrittayakamee S
    PLoS One; 2010 Jul; 5(7):e11880. PubMed ID: 20689583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
    Tran TH; Dolecek C; Pham PM; Nguyen TD; Nguyen TT; Le HT; Dong TH; Tran TT; Stepniewska K; White NJ; Farrar J
    Lancet; 2004 Jan; 363(9402):18-22. PubMed ID: 14723988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria.
    Keating GM
    Drugs; 2012 May; 72(7):937-61. PubMed ID: 22515619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria.
    Tangpukdee N; Krudsood S; Thanachartwet W; Chalermrut K; Pengruksa C; Srivilairit S; Silachamroon U; Wilairatana P; Phongtananant S; Kano S; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1085-91. PubMed ID: 16438129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.
    Leang R; Barrette A; Bouth DM; Menard D; Abdur R; Duong S; Ringwald P
    Antimicrob Agents Chemother; 2013 Feb; 57(2):818-26. PubMed ID: 23208711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
    van der Pluijm RW; Imwong M; Chau NH; Hoa NT; Thuy-Nhien NT; Thanh NV; Jittamala P; Hanboonkunupakarn B; Chutasmit K; Saelow C; Runjarern R; Kaewmok W; Tripura R; Peto TJ; Yok S; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Lek D; Huy R; Dhorda M; Chotivanich K; Ashley EA; Mukaka M; Waithira N; Cheah PY; Maude RJ; Amato R; Pearson RD; Gonçalves S; Jacob CG; Hamilton WL; Fairhurst RM; Tarning J; Winterberg M; Kwiatkowski DP; Pukrittayakamee S; Hien TT; Day NP; Miotto O; White NJ; Dondorp AM
    Lancet Infect Dis; 2019 Sep; 19(9):952-961. PubMed ID: 31345710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children.
    Karema C; Fanello CI; van Overmeir C; van Geertruyden JP; van Doren W; Ngamije D; D'Alessandro U
    Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1105-11. PubMed ID: 16766006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria.
    Denis MB; Davis TM; Hewitt S; Incardona S; Nimol K; Fandeur T; Poravuth Y; Lim C; Socheat D
    Clin Infect Dis; 2002 Dec; 35(12):1469-76. PubMed ID: 12471565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.
    Mayxay M; Keomany S; Khanthavong M; Souvannasing P; Stepniewska K; Khomthilath T; Keola S; Pongvongsa T; Phompida S; Ubben D; Valecha N; White NJ; Newton PN
    Am J Trop Med Hyg; 2010 Dec; 83(6):1221-9. PubMed ID: 21118925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.
    Denis MB; Tsuyuoka R; Poravuth Y; Narann TS; Seila S; Lim C; Incardona S; Lim P; Sem R; Socheat D; Christophel EM; Ringwald P
    Trop Med Int Health; 2006 Sep; 11(9):1360-6. PubMed ID: 16930257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.
    Krudsood S; Looareesuwan S; Silachamroon U; Chalermrut K; Pittrow D; Cambon N; Mueller EA
    Am J Trop Med Hyg; 2002 Nov; 67(5):465-72. PubMed ID: 12479545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.
    Gargano N; Ubben D; Tommasini S; Bacchieri A; Corsi M; Bhattacharyya PC; Rao BH; Dubashi N; Dev V; Ghosh SK; Kumar A; Srivastava B; Valecha N
    Malar J; 2012 Jul; 11():233. PubMed ID: 22818552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.
    Zwang J; Ashley EA; Karema C; D'Alessandro U; Smithuis F; Dorsey G; Janssens B; Mayxay M; Newton P; Singhasivanon P; Stepniewska K; White NJ; Nosten F
    PLoS One; 2009 Jul; 4(7):e6358. PubMed ID: 19649267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
    Ashley EA; McGready R; Hutagalung R; Phaiphun L; Slight T; Proux S; Thwai KL; Barends M; Looareesuwan S; White NJ; Nosten F
    Clin Infect Dis; 2005 Aug; 41(4):425-32. PubMed ID: 16028147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
    Mayxay M; Thongpraseuth V; Khanthavong M; Lindegårdh N; Barends M; Keola S; Pongvongsa T; Phompida S; Phetsouvanh R; Stepniewska K; White NJ; Newton PN
    Trop Med Int Health; 2006 Aug; 11(8):1157-65. PubMed ID: 16903879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial.
    Lon C; Manning JE; Vanachayangkul P; So M; Sea D; Se Y; Gosi P; Lanteri C; Chaorattanakawee S; Sriwichai S; Chann S; Kuntawunginn W; Buathong N; Nou S; Walsh DS; Tyner SD; Juliano JJ; Lin J; Spring M; Bethell D; Kaewkungwal J; Tang D; Chuor CM; Satharath P; Saunders D
    PLoS One; 2014; 9(3):e93138. PubMed ID: 24667662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.